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Abstract In 2004, the first report of TRIM5α as a cellular
antiretroviral factor triggered intense interest among virol-
ogists, particularly because some primate orthologs of
TRIM5α have activity against HIV. Since that time, a
complex and eventful evolutionary history of the TRIM5
locus has emerged. A review of the TRIM5 literature
constitutes a veritable compendium of evolutionary phe-
nomena, including elevated rates of nonsynonymous
substitution, divergence in subdomains due to short
insertions and deletions, expansions and contractions in
gene copy number, pseudogenization, balanced polymor-
phism, trans-species polymorphism, convergent evolution,
and the acquisition of new domains by exon capture.
Unlike most genes, whose history is dominated by long
periods of purifying selection interspersed with rare instan-
ces of genetic innovation, analysis of restriction factor loci is
likely to be complicated by the unpredictable and more-or-
less constant influence of positive selection. In this regard,
the molecular evolution and population genetics of restric-
tion factor loci most closely resemble patterns that have been
documented for immunity genes, such as class I and IIMHC
genes, whose products interact directly with microbial
targets. While the antiretroviral activity encoded by TRIM5
provides plausible mechanistic hypotheses for these unusu-
al evolutionary observations, evolutionary analyses have
reciprocated by providing significant insights into the
structure and function of the TRIM5α protein. Many of
the lessons learned from TRIM5 should be applicable to the
study of other restriction factor loci, and molecular
evolutionary analysis could facilitate the discovery of new
antiviral factors, particularly among the many TRIM genes
whose functions remain as yet unidentified.
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Introduction
The antiviral activity of the TRIM5α protein was first
reported by Stremlau and colleagues, who discovered that a
rhesus monkey ortholog (rhTRIM5α) could protect human
cell lines from infection by HIV-1 (Stremlau et al. 2004).
Subsequent work by a number of groups demonstrated that
TRIM5α from a variety of primates, including apes, Old
World monkeys, and New World monkeys (Diehl et al.
2008; Hatziioannou et al. 2004; Keckesova et al. 2004;
Kono et al. 2008; Saenz et al. 2005; Sawyer et al. 2005;
Song et al. 2005b; Stremlau et al. 2004, 2005; Yap et al.
2005, 2008; Ylinen et al. 2005), as well as related proteins
from cows (Si et al. 2006; Ylinen et al. 2006) and rabbits
(Schaller et al. 2007), have similar antiretroviral activity
when tested against a variety of retroviruses. Analyses of
the TRIM5α protein sequences revealed considerable
interspecies divergence, with much of the variation local-
ized to discrete subdomains in the C-terminal B30.2/SPRY
domain (sometimes referred to as the SPRY or PRYSPRY
domain, and referred to herein as the B30.2 domain). The
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differential retroviral specificities of the various primate
TRIM5α orthologs can be attributed in many cases to
divergence in these variable regions.
There are over 70 TRIM family genes in the human
genome. Genes in the TRIM family characteristically encode
an ordered array of three protein domains (Fig. 1), including
(a) an amino-terminal RING domain, (b) one or two B-box
domains, and (c) a long coiled-coil, which together constitute
the canonical TRIM (tripartite) motif (Reymond et al. 2001;
Sardiello et al. 2008). Most TRIM genes encode an additional
C-terminal domain, which in many cases is a B30.2 domain
(Nisole et al. 2005; Reymond et al. 2001; Rhodes et al. 2005;
Sardiello et al. 2008). The TRIM5 gene encodes multiple
protein isoforms. TRIM5α (product of the longest alternately
spliced transcript) is a cytoplasmic protein that is broadly
expressed in many tissue types (Sawyer et al. 2007). TRIM5α
recognizes the capsid coat of incoming retroviral cores as they
enter newly infected cells, blocking the retroviral replication
cycle during the earliest, post-entry stage(s) of infection
(Fig. 2; Anderson et al. 2006; Hatziioannou et al. 2004;
Perron et al. 2004, 2007; Sebastian and Luban 2005; Shi and
Aiken 2006; Stremlau et al. 2004, 2006; Wu et al. 2006; Yap
et al. 2004, 2006). The precise mechanism of TRIM5α
restriction is still the subject of intense scrutiny, but probably
involves premature disassembly of the capsid core (Anderson
et al. 2006; Perron et al. 2007; Sebastian and Luban 2005; Shi
and Aiken 2006; Stremlau et al. 2006; Wu et al. 2006). The
majority of work published thus far has focused on primate
orthologs of TRIM5α, and collectively, these have been
reported to restrict a variety of divergent retroviral targets,
including both primate and nonprimate lentiviruses, gammar-
etroviruses, betaretroviruses, and spumaretroviruses (Diehl
et al. 2008; Hatziioannou et al. 2004; Keckesova et al. 2004;
Kono et al. 2008; Saenz et al. 2005; Sawyer et al. 2005; Song
et al. 2005b; Stremlau et al. 2004, 2005; Yap et al. 2005,
2008; Ylinen et al. 2005). Primate studies indicate that
TRIM5α proteins have the potential to affect immunity
against HIV, but like all other layers of potential human
immunity to this viral pathogen, the human TRIM5 ortholog
is ineffective against HIV (Stremlau et al. 2004).
Fig. 1 The TRIM5 gene. The human TRIM5 gene is approximately
21 kb in length. Several alternately spliced RNA transcripts are
produced from this gene, one of which encodes the TRIM5α protein.
This protein contains a RING domain, a B-box2 domain, and a coiled-
coil domain, the three signature domains of the TRIM gene family.
The α possesses encodes an additional C-terminal B30.2 domain. The
B30.2 domain is sometimes referred to as the SPRY, PRYSPRY, or








Fig. 2 TRIM5α blocks an early
step in retroviral infection. An
HIV virion is shown infecting a
target cell. The cytoplasmic
TRIM5α protein interacts with
the capsid core of incoming
retroviral particles, subsequently
blocking the retroviral life cycle
at a step before reverse
transcription
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Evolutionary analysis has provided many insights into
how the TRIM5α antiretroviral protein works. It is clear
that this protein has been co-evolving with retroviruses for
tens of millions of years, a relationship whose origins may
predate the radiation of eutherian mammals. This long-
term, evolutionary “arms race” has demanded many
functional innovations in TRIM5α, including short inser-
tions/deletions and tandem duplications in discrete sub-
domains of the protein, rapid sequence change and elevated
levels of nonsynonymous substitution, balanced polymor-
phisms, and structural variation including expansions of
gene copy number and exon shuffling/trapping. The B30.2
domain of TRIM5α has been found to be the major
determinant of viral specificity, and extreme rates of
positive selection of protein sequence are found within
short stretches of this domain (Sawyer et al. 2005). At least
twice in the course of primate evolution TRIM5–cyclo-
philin A chimeric proteins arose via the capture of new
exons (Brennan et al. 2008; Liao et al. 2007; Newman et al.
2008; Nisole et al. 2004; Sayah et al. 2004; Virgen et al.
2008; Wilson et al. 2008b). The TRIM family is vigorously
engaged in gene duplication (Nisole et al. 2005; Reymond
et al. 2001; Sardiello et al. 2008), and in some mammalian
genomes, expansions, inversions, and deletions of the
TRIM5 locus itself are evident (Sawyer et al. 2007; Tareen
et al. 2009). Given abundant evidence that retroviral
pathogens have been ubiquitously present throughout
primate evolution (Gifford and Tristem 2003; Johnson
2008; Lower et al. 1996; Mager and Freeman 1995;
Sverdlov 2000; Weiss 2006; Blikstad et al. 2008), and the
variety of retroviruses that are known to colonize extant
primates (Vogt 1997), it is reasonable to hypothesize that
primate TRIM5α has long played, and continues to play, a
role in governing patterns of susceptibility to cross-species
transmission and spread (within species) of retroviral
pathogens (Song et al. 2005a).
The evolutionary analysis of TRIM5 holds lessons that
will translate well to the study of other intrinsic antiviral
factors. Unlike many genes, whose histories are dominated
by long periods of purifying selection, molecular evolution
of TRIM5 is characterized by frequent episodes of positive
selection (Liu et al. 2005; Ortiz et al. 2006; Sawyer et al.
2005, 2007), and this must be taken into account when
interpreting the results of phylogenetic reconstruction and
other molecular evolutionary analyses. In this regard,
TRIM5 most closely resembles genes of the innate and
adaptive immune system. As with any locus displaying
high levels of divergence and polymorphism, one cannot
assume that a TRIM5 sequence retrieved from a single
genome project or from a single biological sample
represents fixed interspecies differences or the most
common allele. At a minimum, additional sampling of
multiple, unrelated individuals is required to ensure that
species-specific generalizations are based on major allele
(s). A similar caution applies to the viral targets frequently
employed in tissue culture studies of restriction: for
decades, isolation of many laboratory retroviral strains
involved rescue or propagation on convenient, heterologous
cell lines, often from unrelated species, such that the
isolation process itself could have selected for viral
sequences that were rare or absent in the natural host.
Finally, reports of TRIM5α antiviral activity are almost
exclusively based on restriction of retroviral clones com-
monly studied in the laboratory, whose patterns of
sensitivity/resistance to any given TRIM5α ortholog may
simply be due to chance cross-reactivity and not the result
of a prior evolutionary encounter. Thus, establishing
restriction activity for any given TRIM5α variant depends
on those viruses against which it is tested, and the absence
of demonstrable antiviral activity may only mean that
restriction of a complementary target was not attempted. In
fact, it is possible that a given TRIM5α sequence may be
highly specific for viral targets that no longer exist.
Retroviruses as a long-term selective pressure
Human genomes each contain around a half-million
remnants of integrated retroviruses, comprising approxi-
mately 8% of the total genomic sequence. In this regard, the
amount of sequence derived from retroviral integration
exceeds the amount devoted to encoding cellular proteins
(Lander et al. 2001). Such loci are referred to as
endogenous retroviruses (or ERV), despite the fact that a
majority are sufficiently degraded such that they are no
longer capable of expressing infectious virus (for a recent
review see (Jern and Coffin 2008)). A similar endogenous
retroviral load is also found in the genomes of the
chimpanzee and rhesus macaque (Mikkelsen et al. 2005;
Gibbs et al. 2007; Han et al. 2007), and there are large
numbers of these elements in the genomes of other
mammals (Gibbs et al. 2004; Gifford and Tristem 2003;
Lindblad-Toh et al. 2005; Pontius et al. 2007). Collectively,
millions of such elements distributed among the genomes
of different species represent an immense “fossil” record of
the Retroviridae, extending back over hundreds of millions
of years (Coffin 2004). It is likely that the majority of
exogenous retroviral infections leave no such record
(Johnson 2008), so the millions of ERVs represent only a
tiny and potentially biased fraction of the true extent and
variety of retroviral infections encountered by a given host
lineage. These observations cumulatively suggest that
modern primates (including humans) and their ancestors
evolved in a landscape rich with retroviral pathogens, and
that HIV is only the most recent chapter in a voluminous
history of retrovirus–host interactions.
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Most primate endogenous retroviruses identified to date
resemble exogenous gamma- and betaretroviruses. While it
has been widely assumed that the lentiviruses are of
relatively recent origin, dating based on sequence diver-
gence between pairs of duplicated endogenous lentivirus
elements in the genome of European rabbits (Katzourakis et
al. 2007) established that these viruses have been around
for at least seven million years, if not longer. This raises the
intriguing possibility that ancient HIV-like viruses may
have contributed to patterns of evolution still discernible in
the TRIM5 loci of living mammalian taxa. It has long been
suggested that lentiviruses may not be prone to germline
integration due to tissue specificity or other properties of
their life cycle. However, sequences unambiguously related
to the primate lentiviruses (HIV and SIV) have recently
been discovered in the genome of a Malagasy primate, the
gray mouse lemur (Microcebus murinus; Gifford et al.
2008), indicating that the dearth of endogenous lentiviruses
may simply be a result of the fact that lentiviruses are a
relatively new family of retroviruses.
Structural diversity in TRIM5
TRIM5 gene gain and loss The TRIM5 gene is estimated to
be between 90 and 180 million years old (Sawyer et al.
2007). TRIM5 homologs have been described in the
genomes of primates, mouse, rat, dog, cow, and pig, but
are not found in the genome sequence of chicken,
suggesting a mammalian origin (Sawyer et al. 2007; Tareen
et al. 2009). Because no TRIM5 ortholog exists in the
current release of the single marsupial genome project
(opossum), it is possible that TRIM5 may be specific to
eutherian mammals. It is clear that this locus has not been
conservatively inherited through eutherian evolution
(Fig. 3). The genomes of cow, rat, and mouse contain
expanded arrays of TRIM5 genes, while the human genome
contains a single TRIM5 gene, and the dog genome has lost
TRIM5 altogether as the result of a relatively recent gene
disruption (Sawyer et al. 2007; Tareen et al. 2009). In
addition to primate orthologs of TRIM5, antiviral activity
has been reported for rabbit and cow TRIM5 genes
(Schaller et al. 2007; Si et al. 2006; Ylinen et al. 2006).
So far, no antiviral activity has reported for the TRIM5
genes of mice and rats (Fig. 3; Tareen et al. 2009). It is easy
to imagine that TRIM5 gene duplications in certain species
(cow, rat, mouse) might have been selectively retained, with
new paralogs providing an opportunity for simultaneous
selection for multiple CA specificities. Among the cow
TRIM5 genes, only TRIM5-3 has been shown to be an
antiviral; it is not yet known whether the other cow TRIM5
genes have antiviral activity. It is possible that some are
specific for viruses that are not yet known to science (or
which may no longer exist), and without the proper target,
it will be difficult to prove that they are antiviral.
It is unclear why the dog genome has tolerated the loss
of TRIM5. Perhaps there was no significant fitness cost to
losing the TRIM5 gene, although it seems unlikely that
retroviruses would not have been a pathogenic threat for
dogs or their ancestors. Surprisingly, despite their long
association with humans as companion animals and
frequent use as research subjects, there are no confirmed
reports of exogenous retroviruses isolated from dogs.
However, the dog lineage has experienced historical
retroviral infections, as witnessed by the many endogenous
retroviruses present in the canine genome (Lindblad-Toh
et al. 2005). Other genes may have provided sufficient
defense against retroviral infections of the canine lineage.
By analogy to the murine Fv1 and Fv4 loci (Best et al.
1996; Ikeda et al. 1985), perhaps a subset of canine ERV-
related loci could partially fulfill this function. Alternately,
other TRIM genes may be fulfilling this role in dogs
(Sawyer et al. 2007). In primate genomes (human,
chimpanzee, and rhesus), TRIM5 is found in a cluster of
four genes (TRIM6, TRIM34, TRIM5, and TRIM22), and
phylogenetic analyses indicate that these four expanded
from a common ancestral TRIM locus (Sawyer et al. 2007;
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Fig. 3 Structural variation in the TRIM5 locus. The TRIM5 loci of
five eutherian mammals are depicted. Humans encode one active
TRIM5 gene. The human TRIM5 pseudogene (TRIMP1) is supported
by mRNA AF230412 and combines a region of the neighboring gene,
TRIM34, with a region within TRIM5. Mouse, rat, dog, and cow all
encode variable numbers of TRIM5 genes. In dog, there is only one
TRIM5 gene, but it has been interrupted by a gene insertion and has
apparently decayed into a pseudogene. In contrast, mouse, rat, and
cow all encode multiple TRIM5 genes. The mouse TRIM5 locus
contains 8 TRIM5 genes predicted to encode open reading frames.
Two of the mouse TRIM5-like genes were previously known as
TRIM12 and TRIM30 in the literature. Phylogenetic analysis revealed
that the remaining mouse TRIM5 genes form clades with either
TRIM12 or TRIM30; hence, these TRIM5 genes were named according
to their order on the chromosome and the clade to which they belong
(TRIM12-1, 12-2, and TRIM30-1, 30-2, and so on). In the case of the
rat TRIM30s, it was not possible to determine 1:1 orthology to the
different mouse TRIM30 genes. For this reason, the rat genes were
named rat TRIM30-like 1 (L1) or rat TRIM30-like 2 (L2), so as not to
mistakenly imply orthology to mouse TRIM30-1 and 30-2. This
pattern of gene duplication and/or loss suggests that the TRIM5 gene
locus has been highly dynamic in gene content, in addition to the
dynamic sequence evolution that has been observed in these genes
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suggest that human TRIM22 may also have anti-HIV
activity, although the two papers propose unrelated mech-
anisms targeting different aspects of the viral replication
cycle (Barr et al. 2008; Tissot and Mechti 1995). Patterns of
TRIM22 sequence evolution among primates are also
suggestive of strong positive selection, consistent with the
possibility that TRIM22 may have played a role in host
defense (Sawyer et al. 2007). Weak restriction of SIV has
also been reported for human TRIM34 (Li et al. 2007;
Zhang et al. 2006), making these TRIM genes candidate
restriction factors in dogs. However, selective breeding of
dogs over the last two centuries could simply have resulted
in chance fixation of the disrupted TRIM5 allele (regardless
of any increased susceptibility to retroviral pathogenesis),
just as it has resulted in fixation of deleterious alleles of
many other genes (Bjornerfeldt et al. 2006; Wayne and
Ostrander 2007). Surveys of additional canid species should
reveal the timing of the TRIM5 disruption and shed light on
this issue. The lack of a functional TRIM5 may explain the
sensitivity of several dog cell lines to laboratory retroviral
infection and their widespread use as target cell lines in
viral infectivity assays, although this remains to be
explored. Interestingly, experimentally introduced TRIM5α
proteins appear to be less potent when expressed in canine
cell lines than in other cell types (Berube et al. 2007; Saenz
et al. 2005), although it is still not clear why this is the case.
Independent evolution of TRIM5–CypA chimeras in two
primate lineages In 1999, Hoffmann et al. reported the
results of a survey of primate cell lines, tested for
susceptibility to single-round infection with HIV-1(Hofmann
et al. 1999). Because many of the cell types available were
not from tissues expressing the natural viral surface
receptors, the viruses were pseudotyped with the pantropic
envelope glycoprotein of the vesicular stomatitis virus
(VSV-G). Several interesting observations from the Hoff-
man paper were to remain unexplained until the discovery
of TRIM5α-mediated restriction several years later. Among
these was the finding that cells from South American owl
monkeys (Aotus sp.) were resistant to HIV-1 infection, a
point of contrast to most other New World species tested.
Even more puzzling was the observation that treatment of
owl monkey cells with a cyclophilin A agonist relieved this
block (Towers et al. 2003). The explanation arrived when it
was discovered that owl monkey cells express an messen-
ger RNA (mRNA) encoding a TRIM5-cyclophilin A fusion
protein, the consequence of a cyclophilin A (CypA)
pseudogene situated in the short intron between exons 7
and 8 of the owl monkey TRIM5 locus (Fig. 4; Nisole et al.
2004; Sayah et al. 2004). It has been known for many years
that cellular CypA binds to the capsid protein of HIV-1
(Franke et al. 1994; Luban et al. 1993; Thali et al. 1994);
thus, the TRIM5–CypA fusion expressed in owl monkey
cells essentially couples the HIV-1 recognition property of
CypA to the antiviral mechanism(s) encoded by TRIM5.
Unlike human cell lines, where treatment with cyclosporine
A reduces HIV-1 infectivity by interfering with CypA
binding (Braaten et al. 1996; Dorfman and Gottlinger 1996;
Franke and Luban 1996), in Aotus cells cyclosporine A
enhances infectivity indirectly, by preventing inhibition by
the TRIM5–CypA fusion protein (Nisole et al. 2004; Sayah
et al. 2004; Towers et al. 2003).
The CypA ORF in the owl monkey TRIM5 locus is
flanked by direct repeats of genomic DNA sequence, a
hallmark of LINE-1-mediated retrotranspositional insertion
(Nisole et al. 2004; Sayah et al. 2004). Ribeiro et al.
reported that all species of owl monkeys examined
contained the CypA insertion (Ribeiro et al. 2005).
However, inspection of the syntenic position in the genome
sequence of another New World monkey, Callithrix jacchus
(marmoset), reveals a preserved pre-insertion target site.
Thus, the TRIM5–CypA variant may have arisen in a
common ancestor of all modern owl monkeys. Because of
this, the TRIM5–CypA variant is probably fixed in extant
species of the Aotus genus.
Amazingly, expression of a second TRIM5–CypA
chimera was discovered in old world monkeys of the
Macaca genus (Liao et al. 2007). Similar to the owl
monkey TRIM5–CypA variant, macaque TRIM5–CypA
expression results in part from the presence of a retro-
transposed CypA coding sequence in the TRIM5 locus. The
CypA insertion in macaques, however, is clearly distinct





Fig. 4 Independent evolution of genes encoding TRIM5–cyclophilin
A fusion proteins in two different primate lineages. The figure depicts
the TRIM5 locus found in the New World owl monkeys (top) and the
TRIM5–CypA allele found in Asian macaques (bottom). Both loci
direct expression of TRIM5–CypA fusion proteins (known as
TRIM5CypA1 and TRIM5CypA2, respectively (Stoye and Yap
2008)). In both cases, the CypA moiety is encoded by a CypA ORF
generated by retrotranspositional insertion (orange boxes and arrow-
heads). The insertion events are clearly distinct, with the owl monkey
CypA insertion located in an intron and the macaque insertion in the 3′
UTR. The location of a G/T polymorphism in a 3′splice acceptor is
indicated; the nonfunctional T variant is linked to the CypA insertion
and is thought to favor expression of the TRIM5–CypA isoform. Note
that the macaque variant lacks sequences corresponding to exon 7,
whereas this exon is retained in the owl monkey version
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from the insertion in owl monkeys (Fig. 4; Brennan et al.
2008; Liao et al. 2007; Newman et al. 2008; Virgen et al.
2008; Wilson et al. 2008b). In the macaque version, the
CypA insertion lies within the 3′UTR of TRIM5, down-
stream of all known coding exons. In this case, expression
of an in-frame TRIM5–CypA fusion protein results from
alternative splicing from exon 6 of TRIM5 to a 3′ acceptor
site immediately upstream of the CypA ORF. 3′ splice
acceptors are highly conserved features of exons and are
typically composed of a polypyrimidine tract followed
closely by an AG dinucleotide, which in turn defines the
precise border of the intron and the downstream exon. The
insertion of the CypA element immediately 3′ to a stretch of
pyrimidines, and the presence within the retrotransposed
element of a suitable AG dinucleotide, thus reconstituted
the essential elements of a splice acceptor, and permits in-
frame readthrough and expression of a TRIM5–CypA
chimeric protein when exon 6 of TRIM5 serves as the
splice donor.
Remarkably, the CypA insertion in macaque TRIM5 is
always found linked to a second mutation within the TRIM5
gene, this being a single G-T substitution in the 3′ splice
acceptor at the 5′ boundary of exon 7 (Brennan et al. 2007).
As a consequence of this mutation, splicing to exon 7 is
obliterated and the TRIM5α isoform is not expressed.
Thus, the mutation could have been selected separately as a
result of preferential expression of the TRIM5–CypA
mRNA at the cost of expressing the α isoform mRNA. A
two-nucleotide deletion within the B30.2 domain coding
sequence of the rhesus ortholog of TRIM5–CypA results in
a frameshift and premature stop codon, further ensuring that
a functional TRIM5α isoform probably cannot be
expressed from the TRIM5–CypA allele, at least in rhesus
macaques (Wilson et al. 2008a, b). Thus, the macaque
TRIM5–CypA gene appears to be the culmination of
multiple rounds of evolutionary refinement, although the
exact order of the steps involved is not known.
Thus far, the TRIM5–CypA variant in macaques has
been found in three species of Asian macaque, Macaca
mulatta (rhesus macaques), Macaca nemestrina (pig-tailed
macaques), and Macaca fascicularis (cynomolgus or crab-
eating macaques) (Brennan et al. 2008; Liao et al. 2007;
Newman et al. 2008; Virgen et al. 2008; Wilson et al.
2008b). Two surveys were conducted using samples from
captive rhesus macaques, and in both studies, less than half
of the animals typed carried a copy of TRIM5 containing
the inserted CypA element (allele frequencies of 8% and
25%, respectively; Newman et al. 2008; Wilson et al.
2008b). Rhesus macaques are widely dispersed across Asia,
and thus far the insertion has only been reported among
Indian origin rhesus macaques (Wilson et al. 2008b).
Although the numbers may not reveal the true frequency
or distribution among wild populations of rhesus macaques,
it is clear the CypA insertion is not fixed in that species. It is
noteworthy that macaque TRIM5–CypA proteins do not
specifically block HIV-1 infection (but they do block other
lentiviruses), suggesting that the TRIM5-mediated barrier
to HIV-1 infection of rhesus macaques should be absent in
individual macaques homozygous for the TRIM5–CypA
allele (i.e., TRIM5–CypA/TRIM5–CypA homozygotes). This
knowledge may be useful in the further development of
macaques as an animal model for HIV (Ambrose et al. 2007).
It is especially noteworthy that the TRIM5–CypA allele
appears at very high frequency (and may be fixed) in pig-
tailed macaques (M. nemestrina), in which case the entire
species may not express the alpha isoform (TRIM5α).
The lineage leading to the Asian macaques split from the
other African primates about nine to ten million years ago,
and fossil evidence indicates that the ancestors of modern
macaques migrated out of Northern Africa into what is now
Southern Europe and across what is now the Middle East
and Asia (Delson 1975; Raaum et al. 2005; Stewart and
Disotell 1998). A small survey of African sooty mangabeys
(Cercocebus atys), a sister taxon to the Asian macaques, did
not turn up the CypA insertion or the G-T mutation in those
animals (Newman et al. 2008); likewise, TRIM5α mRNA
has been cloned from a variety of African old world
primates but there are as yet no reports of this TRIM5–
CypA fusion in African species. From this, it is possible to
infer that the formation of the TRIM5–CypA allele,
including the CypA insertion itself and the linked G-T splice
acceptor mutation, occurred sometime between five and ten
million years ago in a common ancestor of modern macaques
(Tosi et al. 2003). This interpretation is complicated,
however, by the possibility of hybridization/introgression
among macaque lineages (Bonhomme et al. 2009; Tosi et al.
2003), such that the TRIM5–CypA allele could have arisen
more recently in one species and subsequently spread to
allied populations/species in the Macaca genus. Further
elucidation of the origins of macaque TRIM5–CypA, and its
timing relative to phylogeographic events in macaque
history, could come from examination of a wider distribution
of extant macaque species.
The owl monkey and macaque TRIM5–CypA genes are
thus far each confined to a single genus (Aotus in one case
and Macaca in the other), and the unique genomic structure
of the owl monkey and macaque variants unambiguously
proves that the two TRIM5–CypA fusions evolved inde-
pendently (Fig. 4). Given that CypA is known to bind Gag
of HIV-1 and several other lentiviruses (Franke et al. 1994;
Lin and Emerman 2006; Luban et al. 1993; Thali et al.
1994), and given the well-established antiretroviral activity
of TRIM5α, a scenario can be envisioned in which the
random formation of genetic TRIM5–CypA fusions pro-
vided a selective advantage to their respective hosts in the
face of lentiviral infections.
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The nature of the C-terminal protein domain of the large
TRIM family varies and includes a number of completely
distinct, unrelated protein domains (Nisole et al. 2005;
Reymond et al. 2001; Sardiello et al. 2008). To this list can
now be added to cyclophilin A, having arisen at least twice
during the evolution of modern primates. From this, one
can infer modularity of the two elements (the TRIM motif
and the various C-terminal domains), and that the TRIM
motif has the property of being readily combined with
otherwise unrelated recognition domains. The relatively
recent acquisition of the CypA domains (in evolutionary
time) means that the primary steps involved in the
formation of the new genes could still be elucidated (as
described above); perhaps similar processes, such as
retrotranspositional introduction of new sequences and
“capture” of novel C-terminal exons by alternative splicing,
have played a wider role in the expansion of the TRIM
family.
TRIM5 sequence evolution
Extreme TRIM5 sequence divergence between primate
species In addition to structural variations that distinguish
the TRIM5 locus in different lineages, interspecies compar-
isons also reveal considerable variation at the nucleotide
level. TRIM5 displays some of the highest relative rates of
nonsynonymous change (dN/dS) in primate genomes (Liu
et al. 2005; Ortiz et al. 2006; Sawyer et al. 2005, 2007),
suggesting that it has been adapting through repeated
rounds of positive selection. There are currently over 30
primate TRIM5 sequences available in Genbank. These
sequences represent geographically distributed primate
species from around the world, who share their last
common ancestor about 35 million years ago. When dN/
dS values were analyzed along each branch of the primate
phylogeny, nearly universally high signals were observed
(Sawyer et al. 2005). This is also true for deeper, ancestral
branches where these values can be calculated after
reconstruction of ancestral node sequences. These results
suggest that the adaptive evolution of TRIM5, and its
engagement in defense against retroviral infections, has
been occurring for tens of millions of years.
The distribution of positively selected amino acid sites is
not random, but instead these sites fall predominantly in the
B30.2 and coiled-coil domains (Ortiz et al. 2006; Sawyer
et al. 2005; Song et al. 2005a). Multiple, positively selected
codons fall in a very tight cluster at the beginning of the
B30.2 domain, in a “patch” of positive selection that is 11
residues long in the human protein (Sawyer et al. 2005).
Based on the assumption that adaptation will be occurring
at precisely the spot that must evolve to continually keep
step with variation in the capsid proteins (CA) of
retroviruses, it was predicted that this patch represents the
interface with CA. This hypothesis was tested by making
chimeric proteins in the location of this patch, and showing
that the specificity of one TRIM5α protein could be
transferred to another through this method (Sawyer et al.
2005). In fact, substitution of just a single amino acid in
this region of the human protein can convey levels of
restriction of HIV-1 similar to the rhesus protein (Stremlau
et al. 2005; Yap et al. 2005). It turns out that the amino acid
at position 332 in the context of human TRIM5α strongly
influences HIV recognition. Replacement of the arginine at
position 332 with proline, as is found in the rhesus protein,
results in improved restriction of HIV-1 (Li et al. 2006; Yap
et al. 2005). In fact, any nonpositively charged amino acid
at position 332 in the context of human TRIM5α makes the
recognition of HIV-1 CA more efficient (Li et al. 2006).
B30.2 domains are thought to form a “beta-sandwich”
structure, with a series of strands that fold into two parallel
beta sheets (Grutter et al. 2006; Masters et al. 2006;
Ohkura et al. 2006; Seto et al. 1999; Woo et al. 2006a, b).
Interspecies comparisons indicate that the protein sequence
of the beta strand segments tends to be stable in length, in
contrast to the many insertions and deletions in the putative
loops connecting these strands (Sawyer et al. 2005; Song et
al. 2005a). It is assumed that these regions are likely to lie
on the surface of the B30.2 structure, where they may be
available to interact with viral target structures. Several
lineages have experienced expansions and tandem duplica-
tions of short peptide sequences in these regions of the
TRIM5α B30.2 domain. In a particularly dramatic exam-
ple, the third variable region (V3) of the spider monkey
TRIM5α B30.2 domain is 96 residues long (compared to
typical V3 lengths of 32–41 residues for most other primate
orthologs) and appears to be the result of multiple, tandem
sequence duplications. Similarly, the V1 region ranges from
17 to 46 amino acids in length among primates. Whether
such short insertions/deletions served as the substrate for
positive selection remains to be established. Such events are
concentrated in the same regions of the protein that display
high levels of nonsynonymous substitution (Sawyer et al.
2005; Song et al. 2005a), and both types of variation
overlap suspected points of contact between the B30.2
domain and viral CA targets. One could imagine that some
length variants comprised structural adaptations selected to
accommodate complementary features on the exposed
surfaces of viral CA targets, or alternatively, that the extra
sequence generated by insertion/duplication provided addi-
tional genetic material for amino acid variation and
subsequent positive selection. For example, a six nucleotide
insertion/deletion polymorphism in the V1 region of rhesus
macaque TRIM5α (TFP339Q in Fig. 5) is sufficient to
explain differential restriction of HIV-2 (Wilson et al.
2008a) and SIVagmTAN (Newman and Johnson, unpub-
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lished results) by the most common rhTRIM5α alleles, but
it is not clear whether this is due to the small difference in
length or amino acid composition (or both). Similarly, a 20
amino acid duplication found in an African green monkey
TRIM5α ortholog transfers the capacity to restrict SIV-
mac239 when reconstituted in the context of human
TRIM5α (Nakayama et al. 2005). High ratios of non-
synonymous to synonymous mulation have been docu-
mented within the duplicated regions of several of these
expansions, supporting the hypothesis that adaptive change
can occur within these inserted sequences (Sawyer et al.
2005).
TRIM5 diversity in populations Diversity between species
and variation within species arise from the same evolution-
ary mechanisms, albeit representing different timescales
(with divergence between species representing deeper
separations and variation within species representing more
recent events). The discovery of extensive diversity in
TRIM5 between primate species begged the question of
whether the locus would be polymorphic within species as
well, and whether naturally occurring variants differentially
affect susceptibility to retroviral infection or disease
progression. Thus far, reports of extensive within-species
sampling for polymorphism in TRIM5 have been limited to
humans (Sawyer et al. 2006), most commonly in the
context of HIV/AIDS cohorts (Goldschmidt et al. 2006;
Javanbakht et al. 2006; Nakayama et al. 2007; Speelmon et
al. 2006; van Manen et al. 2008), and two species of Old
World monkey (Fig. 5; Newman et al. 2005; Wilson et al.
2008a).
Human polymorphism The observation that one or a few
amino acid changes dramatically alter the ability of
TRIM5α to interact with HIV-1 CA immediately raised
the question of what TRIM5 looks like in different human
populations: Is it possible that humans encode TRIM5α
proteins with a spectrum of potencies against HIV? Several
diversity and epidemiological studies in humans ensued. In
the first study, world diversity in the human TRIM5 gene
was assessed (Sawyer et al. 2006). Of the 37 geographi-
cally/ethnically distinct human samples surveyed, all
encoded an arginine at position 332. Only a handful of
nonsynonymous single nucleotide polymorphisms (SNPs)
were identified, and these were spread throughout the
coding sequence; strikingly, the N-terminal portion of the
B30.2 domain, encompassing the variable regions, was
found to be devoid of polymorphism (Fig. 5). Of the
common protein-altering SNPs, only one (H43Y) was found
to modulate activity against retroviruses in vitro; in this
case, the 43Y allele weakens TRIM5α restriction (Sawyer et
al. 2006). This study brought H43Y forward as a candidate
SNP for differential susceptibility of certain human pop-
ulations, and at least one study has reported an association
between the 43Y/Y genotype and accelerated disease
progression (van Manen et al. 2008). It will be especially
interesting to explore the effects of TRIM5 genotype in
cohorts from Central and South America, where the 43Y
































































































Fig. 5 Comparison of nonsynonymous polymorphism in TRIM5α of
humans, rhesus macaques, and sooty mangabeys. a Despite the large
number of humans surveyed (>1,000 as of this writing), only a small
handful of polymorphic sites have been identified. In contrast, much
smaller surveys of Asian rhesus macaques and the African sooty
mangabeys have revealed extensive polymorphism, particularly in the
C-terminal portion of the coiled-coil domain and the variable portions
of the B30.2 domain. In addition, the TRIM5–CypA variant (not
shown) is also found at significant frequency in rhesus macaques (see
text). Note that humans lack polymorphism in these same regions.
Sites in blue indicate putative shared polymorphisms. The TFP339Q
indel described in the text is indicated in red. H. sapiens human, M.
mulatta rhesus macaque, C. atys sooty mangabey. b A cladogram
depicting the evolutionary relationship among several primate species
is shown, in order to illustrate the pattern of divergence and diversity
at position 332 in the TRIM5α protein (equivalent to position 334 in
the macaque and sooty mangabey orthologs). Arginine (R), proline
(P), and glutamine (Q) appear to have replaced each other repeatedly
during primate evolution. For this reason, position 332 was identified
as a codon position evolving under positive selection. Amazingly,
alleles encoding all three of these variant amino acids were reported in
African sooty mangabeys, and at least two of these (P and Q) were
found in Asian rhesus macaques
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allele is found at high prevalence compared to other parts of
the world, where it is rare (Sawyer et al. 2006).
The most extensive surveys of human TRIM5 polymor-
phism come from analysis of HIV/AIDS cohorts and related
control populations. Studies using these cohorts have sought
associations between variation in TRIM5 and a variety of
outcomes, such as (a) susceptibility/resistance to HIV-1
infection (by measuring allele frequencies in high-risk yet
uninfected individuals), (b) levels of viral replication in HIV-
1-infected individuals, and (c) various indicators of disease
progression among HIV-1-infected individuals. Most studies
have reported weak associations with at least one of these
outcomes, although these independent studies did not arrive
at the same conclusions (Goldschmidt et al. 2006; Javanbakht
et al. 2006; Nakayama et al. 2007; Speelmon et al. 2006; van
Manen et al. 2008). Further work will be required to
determine the source of the discrepancies, and whether these
reflect true biological/genotypic differences between cohorts.
While a large number of sequence variants in human TRIM5
were identified in the course of these studies, very few
nonsynonymous SNPs with significant minor allele frequen-
cies were uncovered. Notably, none of the common human
polymorphisms fall in the B30.2 variable regions or in
previously identified sites of strong positive selection (Fig. 5).
Associations between human TRIM5 variation and other
retroviral infections (HIV-2, HTLV-1, HTLV-2) have not yet
been reported, nor are we aware of TRIM5 association studies
in animal models of retroviral pathogenesis.
TRIM5 polymorphism in Old World monkeys Patterns of
TRIM5 polymorphism in Old World monkeys seems to be
quite different from what is observed in humans. This is the
case in at least two Old World monkey species that have
been surveyed, the Asian rhesus macaque (M. mulatta), and
the African sooty mangabey (C. atys; Newman et al. 2006,
2008; Wilson et al. 2008a, b). These studies revealed
extensive nonsynonymous polymorphism, with high fre-
quency variants present at multiple sites within the B30.2
domain and, surprisingly, in the C-terminal portion of the
coiled-coil (Fig. 5a; Newman et al. 2006). Surveys of other
Asian and African species will be required to determine
whether this pattern is the rule or the exception for primate
TRIM5 loci.
While surveys of human populations have revealed a
lack of coding polymorphism in the variable regions of
B30.2 domain, the TRIM5 gene of both rhesus macaques
and sooty mangabeys have numerous nonsynonymous
polymorphisms in this domain. One of the most striking
examples occurs at position 334 (homologous to position
332 in human TRIM5α). As described above, this position
is an important determinant of retroviral specificity, and all
primate genomes sampled encode either an arginine (R),
proline (P), or glutamine (Q) at this position (representative
species shown in Fig. 5b). While the R found at position
332 in human TRIM5α clearly has a negative impact on
restriction of HIV-1 (Li et al. 2006; Yap et al. 2005), two
different sooty mangabey TRIM5 alleles encoding an R at
this position readily restrict HIV-1 (Newman et al. 2006).
This suggests that the effect of an arginine at this position
may be context-dependent (there are more than a dozen
fixed differences between the human and sooty mangabey
TRIM5α protein sequences), or alternatively, that these
sooty mangabey TRIM5α alleles may engage the HIV-1
CA via an entirely different set of protein–protein contacts.
Based on an extensive analysis of interspecies TRIM5α
B30.2 subdomain recombinants, Ohkura et al. also found
evidence for context dependence of 332R and restriction of
HIV-1 (Ohkura et al. 2006). Most surprisingly, alleles
encoding different amino acids at this site are present in
both species for which polymorphism has been surveyed
(Fig. 5b; P/Q in rhesus macaques and R/P/Q in sooty
mangabeys; Newman et al. 2006; Wilson et al. 2008a, b).
These alleles may be preserved in these populations
through the forces of balancing selection, as they differ to
some degree in their retroviral specificities.
Some positions in the TRIM5 coiled-coil (CC) region of
rhesus macaques and sooty mangabeys also exhibited trans-
species polymorphism, the phenomenon wherein multiple
alleles are inherited and maintained in sister species (Klein
et al. 2007). Outside of the MHC (Hughes and Yeager
1998), examples of trans-species polymorphism in humans
and other primates are rare (Asthana et al. 2005), and the
pattern is a predicted outcome of long-term balancing
selection (Charlesworth 2006). Consistent with this inter-
pretation, synonymous polymorphisms in the OWM TRIM5
locus clustered tightly around regions of nonsynonymous
polymorphism. Such clustering of synonymous SNPs is
also an expectation of balancing selection maintained over
long evolutionary periods, as recombination between alleles
at regions distal to the sites targeted by selection homog-
enizes sequences, and silent SNPs closely linked to sites
that are the actual targets of balancing selection persist over
longer periods (Charlesworth 2006). Among the sites found
to be polymorphic within M. mulatta and C.atys were sites
independently reported to have high dN/dS values in
interspecies comparisons of the primate TRIM5 locus
(Sawyer et al. 2005). Taken together, these observations
suggest that the CC domain of TRIM5 was also subjected to
bouts of positive selection during the course of primate
evolution.
There are several hypothetical scenarios to explain
positive selection operating on the CC domain, although
they are all speculative. The only well established function
of the CC thus far is to promote TRIM5α multimerization
(Kar et al. 2008; Langelier et al. 2008; Mische et al. 2005).
However, at least one report indicated that the CC may
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sometimes play a role in target specificity (Yap et al. 2005),
and variation in this region, as with the B30.2 domain,
could therefore reflect adaptations for recognition of
different retroviral targets. An indirect influence of the CC
on specificity can also be imagined, wherein amino acid
changes have been selected to modulate the spatial
arrangement of the neighboring B30.2 domains, thus
augmenting interactions with multimeric retroviral CA
structures. For gene systems with multiple, intermediate
frequency alleles (and thus high heterozygosity), the
potential for negative interference between alleles of a
multimerizing protein also exists; thus, another possibility
is that variation in the CC represents secondary adaptations
to reduce or alter interactions between proteins encoded by
alleles of differing specificities. Finally, an interesting
possibility is that the CC domain is the target of viral
factors that actively antagonize TRIM5α function, and
changes in this domain represent “escape” from such
factors. There is ample precedence for such interactions in
retroviral systems, most notably interactions between the
lentiviral Nef, Vif, and Vpu proteins and their respective
host cell targets, MHC class I, APOBEC3G, and Tetherin
(Collins et al. 1998; Neil et al. 2008; Sheehy et al. 2002).
Thus, it is hypothetically possible that in some species the
TRIM5 CC has evolved to evade virally encoded antagonist
(s) of TRIM5α restriction.
Paleovirology
Why is the human version of TRIM5α so poor at restricting
HIV? Sawyer and colleagues have hypothesized that the
paucity of nonsynonymous polymorphism in the variable
portion of the human TRIM5 B30.2 domain was the result
of a selective event in the human lineage, possibly due to a
retroviral pathogen (Sawyer et al. 2006). This previous viral
dodge could have left us in a state of uniform susceptibility
to the most serious retroviral pathogen modern humans
have faced. It is possible that sequences of the virus
responsible for this ancient selective sweep could still be
present among the thousands of ERVs in our genomes, or in
the genomes of species closely related to humans. In fact,
several groups have resurrected ancient, inactivated endog-
enous retroviruses (or their CA proteins), with the potential
to test their sensitivity to human TRIM5α (Dewannieux et
al. 2006; Kaiser et al. 2007; Lee and Bieniasz 2007). Parts
of the Gag protein of two endogenous retroviruses from the
chimpanzee genome, PtERV/CERV1 and CERV2, two
endogenous retroviruses from the rhesus macaque genome,
RhERV1 and RhERV2, and an entire genomic reconstruc-
tion of a “young” human endogenous retrovirus, HERV-K
(HML-2), have now been tested (Kaiser et al. 2007; Lee
and Bieniasz 2007; Perez-Caballero et al. 2008). One group
found that human TRIM5α, which is poor at restricting
HIV, effectively restricts a recombinant retrovirus that
contains the CA and p12 proteins of PtERV (Kaiser et al.
2007), although interestingly, another group did not observe
this restriction when using a recombinant virus containing
only the CA derived from PtERV (Perez-Caballero et al.
2008). In a similar vein, at least one group has attempted to
use phylogenetic methods to reconstruct ancestral TRIM5α
proteins (inferred from ancestral nodes) and tested these for
activity against several modern retroviruses (Goldschmidt
et al. 2008). Among other things, these authors reported
that a predicted ancestral TRIM5α of Old World primates
(~25 million years old) was more effective against HIV-1
than the variant found in modern humans. This is perhaps
not surprising if one considers that, upon zoonotic
transmission, HIV was counter-selected for resistance to
human TRIM5α. It might prove interesting to test ancestral
TRIM5α reconstructions such as these for activity against
capsids derived from ancient ERV loci, such as those
described above.
TRIM5: lessons in retroviral immunity, lessons
in molecular evolution
Although we are currently unaware of any direct evidence
demonstrating that TRIM5α expression modulates or prevents
retroviral infections in nature, such a role can be inferred from
laboratory experiments, and additional evidence may still
come from human cohort studies or animal models. Impor-
tantly, given (a) the demonstrable antiretroviral activity
displayed by a variety of TRIM5α orthologues in tissue
culture, (b) lineage-specific differences in TRIM5α specificity,
and (c) strong evidence of positive selection operating on the
TRIM5 gene, it is reasonable to hypothesize that TRIM5
played a role in governing patterns of spread of retroviruses
within and among ancestral species, and that naturally
occurring variation in the TRIM5 locus of extant species
continues to determine patterns of cross-species transmission
(including zoonotic infections) and drives adaptation of
retroviruses during the process of colonizing a new host.
To date, the bulk of published work on TRIM5 is related to
the structure and function of the TRIM5α protein, but TRIM5
also constitutes a highly attractive target for molecular
evolutionary analyses. The apparent specificity of TRIM5α
for a specific class of pathogen (the Retroviridae) provides, as
a starting point for such studies, a source of well-defined and
plausible evolutionary hypotheses. Such studies are further
complemented by the existence of a vast “fossil” record
comprised of the millions of ancient endogenous retroviruses
embedded in the genomes of modern species, and the large
catalogue of modern, infectious retroviruses found in nature.
From a practical perspective, molecular evolutionary and
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population genetic analyses of TRIM5 can be wed to
functional/structural insights drawn from almost a century
of basic research on animal retroviruses, lending strength to
evolutionary hypotheses derived from sequence analysis. The
antiretroviral activity of TRIM5 is a fairly recent discovery,
yet existing studies of this gene have exposed evidence of a
complex and fascinating evolutionary history. The ancient
origins of TRIM5 (and its presence in widely divergent
mammalian lineages) and its membership in a large and
mostly uncharacterized gene family further ensure a wealth of
material for future studies.
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